Johnson & Johnson’s Icotyde receives US FDA approval for first-line systemic treatment of plaque psoriasis with a targeted oral peptide: Spring House, Pennsylvania Friday, March ...

Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE ...

Around-the-clock performances presented using cutting-edge holograms intended to show hundreds of thousands of visitors ...

Join us as Christopher Pearson gets ready for his next big challenge by warming up with skilled trainer Nate Jones on the ...

Felicia Pearson talks stepping into Cleo’s role in Je’Caryous Johnson’s Set It Off stage adaptation, reflecting on Snoop, stage craft, and cultural legacy.

Lynn Forester de Rothschild, a British philanthropist, has struck a deal to sell her stake in The Economist to a little-known ...

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...

Xbox players across Windows Centra communities share which OG Xbox and Xbox 360 classics they want revived through backward compatibility.

Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a ...

Find all the best things to do in Pittsburgh this weekend, from NatureFest to the Pittsburgh Fringe Festival to the Japanese Film Festival.

The partnership between Pearson India and Infinity Learn reflects a broader shift in India’s test preparation sector, where AI, analytics, and trusted academic content are reshaping how students ...

Significantly more patients treated with once-daily, oral Sotyktu achieved an ACR20 response compared with placebo at ...